{"id":"https://openalex.org/W1984861577","doi":"https://doi.org/10.1159/000080705","title":"Can Erythropoietin Therapy Improve Survival?","display_name":"Can Erythropoietin Therapy Improve Survival?","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W1984861577","doi":"https://doi.org/10.1159/000080705","mag":"1984861577","pmid":"https://pubmed.ncbi.nlm.nih.gov/15486447"},"language":"en","primary_location":{"id":"doi:10.1159/000080705","doi":"https://doi.org/10.1159/000080705","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000080705","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Glaspy","raw_affiliation_strings":["University of California, Los Angeles School of Medicine, 90095, USA. jglaspy@mednet.ucla.edu","University of California, Los Angeles School of Medicine, Los Angeles, Calif., USA, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles School of Medicine, 90095, USA. jglaspy@mednet.ucla.edu","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"University of California, Los Angeles School of Medicine, Los Angeles, Calif., USA, and","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112784629","display_name":"Juergen Dunst","orcid":"https://orcid.org/0000-0003-4590-1972","observed_orcids":["https://orcid.org/0000-0003-4590-1972"]},"institutions":[{"id":"https://openalex.org/I68956291","display_name":"Martin Luther University Halle-Wittenberg","ror":"https://ror.org/05gqaka33","country_code":"DE","type":"education","lineage":["https://openalex.org/I68956291"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Juergen Dunst","raw_affiliation_strings":["Martin Luther University Halle-Wittenberg, Halle, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Martin Luther University Halle-Wittenberg, Halle, Germany","institution_ids":["https://openalex.org/I68956291"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.9866,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.90682259,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"67","issue":"Suppl. 1","first_page":"5","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erythropoietin-therapy","display_name":"erythropoietin therapy","score":0.9100000262260437},{"id":"https://openalex.org/keywords/epoetin-beta","display_name":"epoetin beta","score":0.9179999828338623},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8659999966621399},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.796999990940094},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6320000290870667},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.9900000095367432}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.906901478767395},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7230702638626099},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6866559386253357},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.5897977948188782},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5167405009269714},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5044716596603394},{"id":"https://openalex.org/C2776164570","wikidata":"https://www.wikidata.org/wiki/Q5383794","display_name":"Epoetin alfa","level":3,"score":0.48999133706092834},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44844019412994385},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4456680715084076},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.4238562285900116},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.320102334022522},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2751976251602173},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07725280523300171},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000747","descriptor_name":"Anemia, Hypochromic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000747","descriptor_name":"Anemia, Hypochromic","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015201","descriptor_name":"Meta-Analysis as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000080705","doi":"https://doi.org/10.1159/000080705","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000080705","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},{"id":"pmid:15486447","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15486447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1472022246","https://openalex.org/W1503662436","https://openalex.org/W1885881044","https://openalex.org/W1919092210","https://openalex.org/W1980842970","https://openalex.org/W2002189627","https://openalex.org/W2002395765","https://openalex.org/W2003993212","https://openalex.org/W2011332991","https://openalex.org/W2014481700","https://openalex.org/W2016310876","https://openalex.org/W2028358568","https://openalex.org/W2057968408","https://openalex.org/W2070996288","https://openalex.org/W2071393494","https://openalex.org/W2071674957","https://openalex.org/W2082250901","https://openalex.org/W2086851703","https://openalex.org/W2091061603","https://openalex.org/W2098002323","https://openalex.org/W2111139930","https://openalex.org/W2111485128","https://openalex.org/W2146353390","https://openalex.org/W2400615448","https://openalex.org/W4296277331"],"related_works":["https://openalex.org/W2170790254","https://openalex.org/W1991356850","https://openalex.org/W2041209059","https://openalex.org/W2171137595","https://openalex.org/W2169194873","https://openalex.org/W2152464803","https://openalex.org/W2338760269","https://openalex.org/W2098254080","https://openalex.org/W2016310876","https://openalex.org/W2074947503"],"abstract_inverted_index":{"The":[0,43],"presence":[1],"of":[2,25,37,45,78,120,128,132,149,163,175,186,191,200,209,223,238],"anaemia":[3,38],"in":[4,66,72,90,92,105,134],"patients":[5,94,136,240],"with":[6,10,96,137,151,205,241,243],"cancer":[7,68,138,242],"is":[8,203,246],"correlated":[9],"poor":[11],"clinical":[12],"outcome,":[13],"a":[14,88,125,157,172,206],"reduced":[15,207],"tumour":[16,210],"response":[17],"to":[18,31,34,146],"anticancer":[19],"therapy":[20,51,202],"and":[21,69,74,100,171,229,248],"an":[22],"increased":[23],"risk":[24,208,222],"mortality.":[26],"This":[27,154,212],"observation":[28],"has":[29],"led":[30],"speculation":[32],"as":[33],"whether":[35],"treatment":[36,115,237],"can":[39],"enhance":[40],"survival":[41,91,109,141,162],"rates.":[42],"majority":[44],"studies":[46],"have":[47,86,112,116],"suggested":[48],"that":[49,110,139,198,216,236],"erythropoietic":[50],"either":[52],"does":[53],"not":[54],"change":[55],"or":[56,226],"improves":[57],"disease-free":[58],"and/or":[59],"overall":[60,161,224],"survival.":[61],"Only":[62],"two":[63],"studies,":[64],"one":[65],"breast":[67],"the":[70,118,147,221],"other":[71],"head":[73],"neck":[75],"cancer,":[76],"both":[77],"which":[79],"used":[80],"epoetin":[81,133,192,230,244],"outside":[82],"its":[83],"approved":[84],"indications,":[85],"observed":[87],"decrease":[89],"epoetin-treated":[93],"compared":[95],"controls.":[97],"Methodological":[98],"issues":[99],"baseline":[101],"imbalances":[102],"between":[103,220],"groups":[104],"prognostic":[106],"factors":[107],"for":[108,160,168,180],"may":[111],"favoured":[113],"placebo":[114],"complicated":[117],"interpretation":[119],"these":[121],"studies.":[122],"In":[123],"contrast,":[124],"Cochrane":[126],"meta-analysis":[127,155,185,213],"randomised,":[129,188],"controlled":[130,189],"trials":[131,144,190],"anaemic":[135,239],"reported":[140,156],"identified":[142],"19":[143],"up":[145],"end":[148],"2001":[150],"2,865":[152],"patients.":[153],"hazard":[158,173],"ratio":[159,174],"0.81":[164],"(95%":[165,177],"CI":[166,178],"0.67-0.99)":[167],"adjusted":[169],"data":[170],"0.84":[176],"0.69-1.02)":[179],"unadjusted":[181],"data.":[182],"A":[183],"recent":[184],"nine":[187],"beta":[193,231,245],"(n":[194],"=":[195],"1,413)":[196],"suggests":[197],"use":[199],"this":[201],"associated":[204],"progression.":[211],"also":[214],"showed":[215],"no":[217],"association":[218],"existed":[219],"mortality":[225,228],"thromboembolic":[227],"therapy.":[232],"These":[233],"results":[234],"suggest":[235],"effective":[247],"safe.":[249]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}